Lexicon Pharmaceuticals Files 8-K on Financials
Ticker: LXRX · Form: 8-K · Filed: Mar 6, 2025
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: LXRX
TL;DR
LEXICON PHARMACEUTICALS (LXRX) FILED AN 8-K ON 3/6/25 DETAILING FINANCIALS. CHECK IT OUT.
AI Summary
Lexicon Pharmaceuticals, Inc. filed an 8-K on March 6, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the report date and date of change both being March 6, 2025. The company is incorporated in Delaware and headquartered in The Woodlands, Texas.
Why It Matters
This 8-K filing provides an update on Lexicon Pharmaceuticals' financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial information and does not indicate any unusual or high-risk events.
Key Players & Entities
- LEXICON PHARMACEUTICALS, INC. (company) — Registrant
- March 6, 2025 (date) — Date of earliest event reported
- The Woodlands, Texas (location) — Principal executive offices location
- 2818633000 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Lexicon Pharmaceuticals, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on March 6, 2025.
Where is Lexicon Pharmaceuticals, Inc. headquartered?
Lexicon Pharmaceuticals, Inc. is headquartered at 2445 Technology Forest Blvd., 11th Floor, The Woodlands, Texas 77381.
What is the company's state of incorporation?
The company's state of incorporation is Delaware.
What is the SEC file number for Lexicon Pharmaceuticals, Inc.?
The SEC file number for Lexicon Pharmaceuticals, Inc. is 000-30111.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 6, 2025 regarding LEXICON PHARMACEUTICALS, INC. (LXRX).